Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001385562.1(ARPP21):c.896A>T(p.Asp299Val) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000011 in 1,453,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
ARPP21 (HGNC:16968): (cAMP regulated phosphoprotein 21) This gene encodes a cAMP-regulated phosphoprotein. The encoded protein is enriched in the caudate nucleus and cerebellar cortex. A similar protein in mouse may be involved in regulating the effects of dopamine in the basal ganglia. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jun 2012]
Uncertain significance, criteria provided, single submitter
clinical testing
Ambry Genetics
Nov 23, 2024
The c.896A>T (p.D299V) alteration is located in exon 11 (coding exon 9) of the ARPP21 gene. This alteration results from a A to T substitution at nucleotide position 896, causing the aspartic acid (D) at amino acid position 299 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -